Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.81B |
| 2 |
Microsoft
MSFT
|
+$1.34B |
| 3 |
Apple
AAPL
|
+$1.25B |
| 4 |
Amazon
AMZN
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$480M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$373M |
| 2 |
Amgen
AMGN
|
+$204M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$180M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$160M |
| 5 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.47% |
| 2 | Financials | 12.91% |
| 3 | Healthcare | 12.22% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3676
Newegg Commerce
NEGG
$359M
| $418K | ﹤0.01% |
22,622
+648
| +3% | +$12.4K |
|
3677
Armata Pharmaceuticals
ARMP
$173M
| $418K | ﹤0.01% |
99,888
-1,125
| -1% | -$4.07K |
|
3678
Culp Inc
CULP
$44.1M
| $417K | ﹤0.01% |
86,766
+2,069
| +2% | +$10.4K |
|
3679
Cytosorbents Corp
CTSO
$22.6M
| $416K | ﹤0.01% |
438,297
+73,377
| +20% | +$71.4K |
|
3680
Brookfield Infrastructure Partners
BIP
$18B
| $414K | ﹤0.01% |
13,266
+11
| +0.1% | +$334 |
|
3681
Hanover Bancorp
HNVR
$198M
| $413K | ﹤0.01% |
27,867
+1,230
| +5% | +$20.8K |
|
|
PDS
3682
Precision Drilling
PDS
$974M
| $413K | ﹤0.01% |
6,108
+313
| +5% | +$18.9K |
|
3683
Katapult Holdings
KPLT
$33.2M
| $411K | ﹤0.01% |
35,245
+3,712
| +12% | +$46.1K |
|
3684
DarioHealth
DRIO
$71.2M
| $410K | ﹤0.01% |
13,399
-130
| -1% | -$4.93K |
|
|
ZJYL
3685
Jin Medical International
ZJYL
$16.8M
| $409K | ﹤0.01% |
5,327
| – | – |
|
3686
Rani Therapeutics
RANI
$89M
| $407K | ﹤0.01% |
130,906
+17,277
| +15% | +$59.4K |
|
|
CKPT
3687
DELISTED
Checkpoint Therapeutics
CKPT
| $407K | ﹤0.01% |
198,501
+24,657
| +14% | +$49.2K |
|
3688
Precision BioSciences
DTIL
$207M
| $405K | ﹤0.01% |
29,843
-4
| -0% | -$49 |
|
3689
BayFirst Financial Corp
BAFN
$34M
| $404K | ﹤0.01% |
31,208
+1,228
| +4% | +$15.5K |
|
3690
Auburn National Bancorp
AUBN
$91.9M
| $404K | ﹤0.01% |
20,987
+195
| +0.9% | +$3.99K |
|
3691
Reading International Class A
RDI
$34.3M
| $404K | ﹤0.01% |
219,366
+1,978
| +0.9% | +$3.76K |
|
3692
Clene
CLNN
$67.5M
| $403K | ﹤0.01% |
47,327
+16,733
| +55% | +$145K |
|
3693
Solidion Technology
STI
$61.3M
| $402K | ﹤0.01% |
+2,924
| New | +$508K |
|
3694
Bank Of The James
BOTJ
$124M
| $401K | ﹤0.01% |
38,666
| – | – |
|
|
ICAD
3695
DELISTED
iCAD Inc
ICAD
| $396K | ﹤0.01% |
245,830
+6,454
| +3% | +$10.2K |
|
3696
Grupo Aeroportuario Centro Norte
OMAB
$5.33B
| $392K | ﹤0.01% |
4,954
+5
| +0.1% | +$365 |
|
3697
NextCure
NXTC
$26.7M
| $390K | ﹤0.01% |
14,559
| – | – |
|
|
LKFT
3698
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
| $389K | ﹤0.01% |
12,090
+1,095
| +10% | +$40.7K |
|
3699
Riskified
RSKD
$716M
| $389K | ﹤0.01% |
71,907
+48,137
| +203% | +$229K |
|
3700
Lufax Holding
LU
$1.3B
| $389K | ﹤0.01% |
92,165
-924,029
| -91% | -$2.59M |
|
Similar funds
Geode Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Geode Capital Management held 4,738 positions worth $1.08T, up 13% from $956B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Geode Capital Management deployed $32.6B of net new capital in Q1 2024, opening 85 new positions and adding to 3,720 existing holdings. Its largest new stake was Solventum: 2,733,775 shares worth $0.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $204M trimmed.
- Geode Capital Management's largest Q1 2024 buy was Solventum: 2,733,775 shares worth $0.
- Geode Capital Management added most to NVIDIA in Q1 2024, an estimated $1.81B increase.
- Geode Capital Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $204M.
- Geode Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $373M.
- Geode Capital Management's ten largest holdings make up 28% of its $1.08T portfolio in Q1 2024.
- Geode Capital Management opened 85 new positions and closed 123 in Q1 2024.
- Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $1.08T.
Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.